Company: OFIX
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0000950170-25-026066
Chunk: 165

Company: Orthofix Medical Inc.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 1B
Chunk 165
---
 are subject to FDA inspection to ensure compliance with its Quality System Regulations. For further information regarding the status of FDA inspections, see Item 1, "Business", under the subheading "Government Regulation."

Item 3.	Legal Proceedings

For a description of material pending legal proceedings, refer to Note 13 of the Notes to the Consolidated Financial Statements in Item 8 of this Annual Report.

Item 4.	Mine Safety Disclosures 

Not applicable. 

54

PART II 

Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 

Market for Our Common Stock 

Our common stock is traded on the Nasdaq Global Select Market under the symbol "OFIX". As of February 21, 2025, we had 428 holders of record of our common stock. A substantially greater number of holders of our common stock are "street name" or beneficial holders, whose shares are held by banks, brokers and other financial institutions. The closing price of our common stock on February 21, 2025, was $17.95. The following table shows the high and low sales prices for our common stock for each of the two most recent fiscal years.

    High

    Low

    2023

    First Quarter
     
    $
    23.19

    $
    15.09

    Second Quarter

    20.65

    16.27

    Third Quarter

    21.60

    12.25

    Fourth Quarter

    14.39

    9.57

    2024

    First Quarter
     
    $
    14.90

    $
    12.38

    Second Quarter

    15.90

    12.08

    Third Quarter

    17.67

    12.72

    Fourth Quarter

    20.73

    14.73

Dividends

We have not paid dividends to holders of our common stock in the past and have no present intention to pay dividends in the foreseeable future. Additionally, we have restrictions on our ability to pay dividends in certain circumstances pursuant to our Credit Agreement. We currently intend to retain all of our consolidated earnings to finance the continued growth of our business. 

In the event that we decide to pay a dividend to holders of our common stock in the future with dividends received from our subsidiaries, we may, based on prevailing rates of taxation